Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Gronwald

Showing results (191-200 of 307) with videos related to

Pageof 31
Sort By:
Molecular Cancer Therapeutics|April 9, 2015
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K InhibitionSally J Davis, Karen E Sheppard, Michael S Anglesio, et al.
JAMA Oncology|February 29, 2024
MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence VariationsJan Lubinski, Joanne Kotsopoulos, Pal Moller, et al.
Nutrients|May 11, 2024
Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 CarriersAdam Kiljańczyk, Milena Matuszczak, Wojciech Marciniak, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 5, 2014
The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish menAndrzej Antczak, Dominika Wokołorczyk, Wojciech Kluźniak, et al.
International Journal of Cancer|August 15, 2003
Hereditary ovarian cancer in PolandJanusz Menkiszak, Jacek Gronwald, Bohdan Górski, et al.
International Journal of Cancer|May 18, 2004
A high proportion of founder BRCA1 mutations in Polish breast cancer familiesBohdan Górski, Anna Jakubowska, Tomasz Huzarski, et al.
The Prostate|January 22, 2013
The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in PolandWojciech Kluźniak, Dominika Wokołorczyk, Aniruddh Kashyap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>Kelly-Anne Phillips, Joanne Kotsopoulos, Susan M Domchek, et al.
International Journal of Cancer|September 17, 2013
The presence of prostate cancer at biopsy is predicted by a number of genetic variantsAniruddh Kashyap, Wojciech Kluźniak, Dominika Wokołorczyk, et al.
Plos One|June 16, 2011
Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association ConsortiumGalina Lurie, Lynne R Wilkens, Pamela J Thompson, et al.
Pageof 31

Showing results (191-200 of 307) with videos related to

Sort By:
Pageof 31
Molecular Cancer Therapeutics|April 9, 2015
Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K InhibitionSally J Davis, Karen E Sheppard, Michael S Anglesio, et al.
JAMA Oncology|February 29, 2024
MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence VariationsJan Lubinski, Joanne Kotsopoulos, Pal Moller, et al.
Nutrients|May 11, 2024
Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 CarriersAdam Kiljańczyk, Milena Matuszczak, Wojciech Marciniak, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 5, 2014
The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish menAndrzej Antczak, Dominika Wokołorczyk, Wojciech Kluźniak, et al.
International Journal of Cancer|August 15, 2003
Hereditary ovarian cancer in PolandJanusz Menkiszak, Jacek Gronwald, Bohdan Górski, et al.
International Journal of Cancer|May 18, 2004
A high proportion of founder BRCA1 mutations in Polish breast cancer familiesBohdan Górski, Anna Jakubowska, Tomasz Huzarski, et al.
The Prostate|January 22, 2013
The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in PolandWojciech Kluźniak, Dominika Wokołorczyk, Aniruddh Kashyap, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>Kelly-Anne Phillips, Joanne Kotsopoulos, Susan M Domchek, et al.
International Journal of Cancer|September 17, 2013
The presence of prostate cancer at biopsy is predicted by a number of genetic variantsAniruddh Kashyap, Wojciech Kluźniak, Dominika Wokołorczyk, et al.
Plos One|June 16, 2011
Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association ConsortiumGalina Lurie, Lynne R Wilkens, Pamela J Thompson, et al.
Pageof 31